Literature DB >> 21288834

Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection.

Chengbin Wang1, Xingyou Zhang, Stephanie Bialek, Michael J Cannon.   

Abstract

Congenital cytomegalovirus (CMV) infection is a leading cause of developmental disabilities. In the United States during the period 1988-1994, approximately one-quarter of congenital CMV infections were attributable to primary maternal infection (n = 8772), and three-quarters were attributable to non-primary maternal infection (n = 29,918). Effective prevention strategies need to be developed for both primary and non-primary maternal infections.

Entities:  

Mesh：

Year:  2011        PMID： 21288834     DOI： 10.1093/cid/ciq085

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  96 in total

1.  Rapid genotyping of cytomegalovirus in dried blood spots by multiplex real-time PCR assays targeting the envelope glycoprotein gB and gH genes.

Authors:  Jutte J C de Vries; Els Wessels; Anna M H Korver; Annemiek A van der Eijk; Lisette G Rusman; Aloys C M Kroes; Ann C T M Vossen
Journal:  J Clin Microbiol       Date:  2011-11-23       Impact factor: 5.948

2.  Limits and patterns of cytomegalovirus genomic diversity in humans.

Authors:  Nicholas Renzette; Cornelia Pokalyuk; Laura Gibson; Bornali Bhattacharjee; Mark R Schleiss; Klaus Hamprecht; Aparecida Y Yamamoto; Marisa M Mussi-Pinhata; William J Britt; Jeffrey D Jensen; Timothy F Kowalik
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-06       Impact factor: 11.205

Review 3.  Priorities for CMV vaccine development.

Authors:  Philip R Krause; Stephanie R Bialek; Suresh B Boppana; Paul D Griffiths; Catherine A Laughlin; Per Ljungman; Edward S Mocarski; Robert F Pass; Jennifer S Read; Mark R Schleiss; Stanley A Plotkin
Journal:  Vaccine       Date:  2013-10-13       Impact factor: 3.641

4.  Could therapeutic vaccination of cytomegalovirus-seropositive persons prevent reinfection and congenital virus transmission?

Authors:  Mark R Schleiss
Journal:  J Infect Dis       Date:  2011-06-01       Impact factor: 5.226

5.  Higher Expectations for a Vaccine To Prevent Congenital Cytomegalovirus Infection.

Authors:  Soren Gantt; Arnaud Marchant; Suresh B Boppana
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

6.  Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next?

Authors:  Mark R Schleiss
Journal:  Future Virol       Date:  2013-12       Impact factor: 1.831

Review 7.  Controversies in the natural history of congenital human cytomegalovirus infection: the paradox of infection and disease in offspring of women with immunity prior to pregnancy.

Authors:  William Britt
Journal:  Med Microbiol Immunol       Date:  2015-03-13       Impact factor: 3.402

8.  Incidence of CMV co-infection in HIV-positive women and their neonates in a tertiary referral centre: a cohort study.

Authors:  A Reitter; H Buxmann; A E Haberl; R Schlösser; M Kreibich; O T Keppler; A Berger
Journal:  Med Microbiol Immunol       Date:  2015-07-09       Impact factor: 3.402

Review 9.  Breast milk-acquired cytomegalovirus infection and disease in VLBW and premature infants.

Authors:  Tatiana M Lanzieri; Sheila C Dollard; Cassandra D Josephson; D Scott Schmid; Stephanie R Bialek
Journal:  Pediatrics       Date:  2013-05-27       Impact factor: 7.124

Review 10.  Detection of congenital cytomegalovirus in newborns using nucleic acid amplification techniques and its public health implications.

Authors:  Guoyu Liu; Rong Hai; Fenyong Liu
Journal:  Virol Sin       Date:  2017-10-30       Impact factor: 4.327
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.